“Number of senior citizens age 65 and above to represent 24.15% of the population by 2037 which will propel high demand of drugs”, says RNCOS.

Noida, UP -- (SBWire) -- 04/28/2015 --According to a new research report by RNCOS entitled, "Brazil Pharmaceutical Market Outlook 2018", Brazil, for the first time surpassed the 200 Million inhabitants in 2013, 8% of whom were senior citizens (with age 65 years and above) and 35.26% are young people up to age 14. The economically active population, therefore, is over 50% of the total. The growing ageing population will be one of the important factors to drive the pharmaceutical market. There will be considerable demand for better healthcare services and advanced medical services to cope with the progressing elderly population.

According to the estimates by Brazilian Government's statistical agency Instituto Brasileiro de Geogragiae Estatistica (IBGE), total number of senior citizens will grow faster while the number of young people will decrease by 2037, when senior citizens will represent 24% of the population. In 2041, the elderly population will be 27% of the total population.

The report is spread in over 85 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Brazilian Pharmaceutical industry. The study presents a transparent picture about different pharma segments such as Generics, OTC and Prescription Drugs including the factors affecting their growth. The research further covers Pharmaceutical Production, Therapeutic Segments, Growth Drivers and Challenges as well as Mergers and Acquisitions.

The report also covers detailed information about active market players in the Brazil pharmaceutical industry, including domestic and foreign players to enable the clients understand the market structure and its growth during the forecasted period. In brief, the report covers all the necessary aspects of the Brazilian Pharmaceutical market, providing an in-depth research and prudent analysis of the key segments.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM726.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.